8:22 AM
Leo Group India
| ||
| Pharmaceutical staff told they will be out of job Swindon Advertiser EMPLOYEES at a pharmaceutical company have been dealt a massive blow just weeks before Christmas, as it was announced dozens of staff would lose their jobs. More than 40 staff at Catalent have been told this week that they are to be without a job by ... See all stories on this topic » | ||
| AcelRx phase III study of sublingual Sufentanil NanoTab PCA vs IV PCA ... pharmabiz.com Specialty pharmaceutical company, AcelRx Pharmaceuticals, Inc., has announced top-line data showing that the open-label phase III study of its investigational sublingual (under the tongue) Sufentanil NanoTab PCA (patient-controlled analgesia) System ... See all stories on this topic » | ||
| 6 Pharmaceutical Stocks to Sell Now Investorplace.com Depomed (NASDAQ:DEPO) gets weaker ratings this week as last week's C drops to a D. Depomed is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that address large and growing markets ... See all stories on this topic » | ||
| Clinical Trial Strategies to Ensure Pharmaceutical Success in a Global ... Sacramento Bee 16, 2012 /PRNewswire/ -- Pharmaceutical organizations are experiencing two dynamics in mature markets like North America and Europe: Clinical costs are continuing to rise and sales are either rising negligibly or not at all. In emerging markets ... See all stories on this topic » | ||
| Biostar Pharmaceuticals To Announce 2012 Third Quarter Financial Results And ... Sacramento Bee XIANYANG, China, Nov. 16, 2012 -- /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of ... See all stories on this topic » | ||
| Teva, AstraZeneca reportedly competing to court Irish drug company Amarin Philadelphia Inquirer Philadelphia-area pharmaceutical giants Teva Pharmaceutical Industries Ltd. and AstraZeneca Plc. are trying to rebound after difficult periods, and both are reportedly among the companies competing to buy Amarin Corp. because of a new heart drug about ... See all stories on this topic » | ||
| Alnylam Pharmaceuticals, BioMarin Pharmaceutical Inc., and Cytonet Set to ... MENAFN.COM Quotes: US, MENA, Enter Symbol: NewsLetter: Search: advanced. Alnylam Pharmaceuticals, BioMarin Pharmaceutical Inc., and Cytonet Set to Speak on Conducting Effective Orphan Drug Research at marcus evans Conference Join our daily free Newsletter ... See all stories on this topic » | ||
| PIC/S includes Taiwan and New Zealand regulatory authority under its umbrella ... pharmabiz.com Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme (PIC/S) has now offered New Zealand's Medicines and Medical Devices Safety Authority (Medsafe) as well as Chinese Taipei/ Taiwan Food and Drug Administration ... See all stories on this topic » | ||
| Santhera expects CHMP opinion on its MAA for Raxone(R) early 2013 Reuters Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusedon the development and commercialization of innovative pharmaceutical products for the treatment of orphan neuromuscular and mitochondrial diseases, areas of ... See all stories on this topic » | ||
| Pay-for-Delay Controversy: It's Costing You Billions Motley Fool Branded pharmaceutical companies and generic manufacturers disagree. In a recent article, I reviewed several reasons that the pharma companies think that pay-for-delay arrangements should be allowed to continue. Let's look now at the rationale for ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment